Topic Hub
15 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 15 of 15 clinical reviews.
A clinical evidence summary of oral estradiol's off-label use for cognitive decline prevention, including key trials like WHIMS, KEEPS-Cog, and ELITE, the critical window hypothesis, and current guideline positions.
Read clinical reviewA detailed clinical review of off-label oral estradiol for cognitive decline prevention, covering trial data, GRADE evidence levels, FDA-approved indications, timing considerations, and known risks.
Read clinical reviewEvidence review of off-label oral estradiol for cognitive decline prevention, including dosing protocols, the critical window hypothesis, key trial data from WHIMS and KEEPS, and clinical considerations.
Read clinical reviewOral estradiol is not FDA-approved for cognitive decline prevention. Here is the clinical evidence, timing hypothesis, monitoring requirements, and what the data from WHIMS, KEEPS, and ELITE actually show.
Read clinical reviewDoes oral estradiol improve mood? A physician-reviewed evidence summary covering off-label use, clinical trials, GRADE ratings, dosing, and safety considerations for estradiol oral therapy.
Read clinical reviewA clinician-reviewed guide to oral estradiol's off-label use for mood symptoms, covering the evidence base, GRADE ratings, FDA-approved indications, and key risks to weigh before prescribing.
Read clinical reviewCan oral estradiol improve mood? A detailed look at the off-label evidence, FDA-approved context, GRADE ratings, dosing signals, and monitoring requirements for mood-related prescribing.
Read clinical reviewA clinician-reviewed guide to off-label oral estradiol for mood symptoms, covering the evidence base, GRADE rating, dosing protocols, safety considerations, and how it compares to FDA-approved indications.
Read clinical reviewA clinical evidence summary of oral estradiol for osteoporosis, including FDA-approved prevention indications, off-label treatment use, WHI trial data, dosing, and risk-benefit analysis.
Read clinical reviewEvidence-based guide to using oral estradiol off-label for osteoporosis prevention and treatment, including dosing protocols, clinical trial data, and guideline recommendations.
Read clinical reviewOral estradiol is used off-label for osteoporosis prevention and treatment. Learn the evidence behind this use, required monitoring protocols, and how it compares to FDA-approved therapies.
Read clinical reviewA comprehensive evidence summary on using oral estradiol for feminizing hormone therapy in transgender women, including dosing, efficacy, safety data, and guideline recommendations.
Read clinical reviewOral estradiol is widely prescribed off-label for feminizing hormone therapy in transgender women. Learn about monitoring protocols, target lab values, VTE risk, and evidence-based dosing.
Read clinical reviewEvidence-based guide to oral estradiol dosing for feminizing hormone therapy in transgender women, including off-label status, recommended protocols, monitoring, and risk management.
Read clinical reviewOral estradiol is widely used off-label for feminizing hormone therapy in transgender women. This clinician-reviewed guide covers dosing, VTE risk, cardiovascular tradeoffs, and how oral compares to transdermal routes.
Read clinical review